论文信息 - Efficacy and Safety of Dabigatran Versus Warfarin in Patients with Atrial Fibrillation : Analysis in Asian Population in RE-LY Trial - 字舞流文

Efficacy and Safety of Dabigatran Versus Warfarin in Patients with Atrial Fibrillation : Analysis in Asian Population in RE-LY Trial

Efficacy and Safety of Dabigatran Versus Warfarin in Patients with Atrial Fibrillation : Analysis in Asian Population in RE-LY Trial

S. Yusuf | Jun Zhu | D. Xavier | Li-sheng Liu | P. Pais | A. Dans | C. Lau | M. Ezekowitz | S. Connolly | M. Hori | S. Tanomsup | L. Wallentin | P. Reilly | R. Tan | R. Omar | Sung-Hyuck Kim | J-H Chen | M. Watanabe | M. Koyanagi | J‐H. Chen

[1] Gregory Y H Lip,et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.

[2] M. Pirinen,et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke , 2012, Nature Genetics.

[3] Gregory Y H Lip,et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.